Journal of Cardiac Failure
Volume 16, Issue 4 , Pages 357-366 , April 2010

Effects of Adipose Tissue-Derived Stem Cell Therapy After Myocardial Infarction: Impact of the Route of Administration

  • Montserrat Rigol, MVD, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • Ciber de Enfermedades Respiratorias (CIBERES), Mallorca, Spain
    • Corresponding Author InformationReprint requests: Montserrat Rigol, MVD, PhD, Institut de Clínic del Tòrax, Hospital Clínic de Barcelona, Villarroel, 170, 08036 Barcelona, Spain. Tel: 34-93-2279305; Fax: 34-93-4514148.
    • ,
  • Núria Solanes, MVD, PhD

      Affiliations

    • Both authors contributed equally to this study.
    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Jordi Farré, PhD

      Affiliations

    • ICREC Program, Cardiology Service, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • ,
  • Santiago Roura, PhD

      Affiliations

    • ICREC Program, Cardiology Service, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • ,
  • Mercè Roqué, MD, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Antonio Berruezo, MD, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Neus Bellera, MD

      Affiliations

    • Servei de Cardiologia, Hospital de Vall d'Hebron, Barcelona, Spain
    • ,
  • Laura Novensà, MVD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • David Tamborero, BENG, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Cristina Prat-Vidal, PhD

      Affiliations

    • ICREC Program, Cardiology Service, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • ,
  • MA Ángeles Huzman, MVD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Montserrat Batlle, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Margo Hoefsloot, MD

      Affiliations

    • Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
    • ,
  • Marta Sitges, MD, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • José Ramírez, MD, PhD

      Affiliations

    • Centre de Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain
    • ,
  • Ana Paula Dantas, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Anna Merino, MD, PhD

      Affiliations

    • Centre de Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain
    • ,
  • Ginés Sanz, MD, PhD

      Affiliations

    • Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
    • ,
  • Josep Brugada, MD, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain
    • ,
  • Antoni Bayés-Genís, MD, PhD

      Affiliations

    • ICREC Program, Cardiology Service, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • ,
  • Magda Heras, MD, PhD

      Affiliations

    • Institut Clínic del Tòrax, Institut d'Investigacions Biomèdiques Agustí Pi Sunyer, Hospital Clínic, Barcelona, Spain

Received 3 September 2009 ,Revised 26 November 2009 ,Accepted 9 December 2009.

References 

  1. Agbulut O, Vandervelde S, Al Attar N, Larghero J, Ghostine S, Léobon B, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infracted myocardium. J Am Coll Cardiol. 2004;44:458–463
  2. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, et al. Intracoronary bone marrow cell transfer after myocardial infarction. Eighteen months' follow-up data from the randomized, controlled BOOST trial. Circulation. 2006;113:1287–1294
  3. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J. 2005;26:1188–1195
  4. Beeres SL, Atsma DE, van Ramshorst J, Schalij MJ, Bax JJ. Cell therapy for ischaemic heart disease. Heart. 2008;94:1214–1226
  5. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 2004;14:311–324
  6. Planat-Bénard V, Menard C, André M, Puceat M, Perez A, Garcia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004;94:223–229
  7. Planat-Bénard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells towards endothelial cells: physiology and therapeutic perspectives. Circulation. 2004;109:656–663
  8. Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS, et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol. 2008;103:525–536
  9. Fernández-Avilés F, San Román JA, García-Frade J, Fernández ME, Peñarrubia MJ, de la Fuente L, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res. 2004;95:742–748
  10. Fuchs S, Kornowski R, Weisz G, Satler LF, Smits PC, Okubagzi P, et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. Am J Cardiol. 2006;97:823–829
  11. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomised study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27:1114–1122
  12. Tossios P, Krausgrill B, Schmidt M, Fischer T, Halbach M, Fries WU, et al. Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. Eur Heart J. 2008;29:1911–1921
  13. Rigol M, Solanes N, Sionis A, Gálvez C, Martorell J, Rojo I, et al. Effects of cyclosporine, tacrolimus and sirolimus on vascular changes related to immune response: an experimental study. J Heart Lung Transplant. 2008;27:416–422
  14. Martínez-Estrada OM, Muñoz-Santos Y, Julve J, Reina M, Vilaro S. Human adipose tissue as a source of Flk-1+ cells: new method of differentiation and expansion. Cardiovasc Res. 2005;65:328–333
  15. Farré J, Roura S, Prat-Vidal C, Soler-Botija C, Llach A, Molina CE, et al. FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells. Growth Factors. 2007;25:71–76
  16. Rigol M, Solanes N, Roqué M, Farré J, Batlle M, Roura S, et al. Haemosiderin deposits confounds tracking of iron-oxide labelled stem cells. Transpl Proc. 2008;40:3619–3622
  17. Cai L, Johnstone BH, Cook TG, Tan J, Fishbein MC, Chen PS, et al. IFATS series: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells. 2009;27:230–237
  18. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006;12:459–465
  19. Schenke-Layland K, Strem BM, Jordan MC, DeEmedio MT, Hedrick MH, Roos KP, et al. Adipose tissue-derived cells improve cardiac function following myocardial infarction. J Surg Res. 2009;153:217–223
  20. Valina C, Pinkernell K, Song Y, Bai X, Sadat S, Campeau RJ, et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007;28:2667–2677
  21. Li B, Zeng Q, Wang H, Shao S, Mao X, Zhang F, et al. Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coron Artery Dis. 2007;18:221–227
  22. Zhang D, Gai L, Liu H, Jin Q, Huang J, Zhu X. Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction. Chin Med J. 2007;20:300–307
  23. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005;96:127–137
  24. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infracted myocardium. Nature. 2001;410:701–705
  25. Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR, et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol. 2008;29:H2002–H2011
  26. Gavira JJ, Perez-Ilzarbe M, Abizanda G, García-Rodríguez A, Orbe J, Páramo JA, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovasc Res. 2006;71:744–753
  27. Fukushima S, Varela-Carver A, Coppen SR, Yamahara K, Felkin LE, Lee J, et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation. 2007;115:2254–2261
  28. Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, et al. Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infracted porcine heart. Stem Cells Develop. 2007;16:31–37
  29. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008;29:1807–1818
  30. Herbots L, D'hooge J, Eroglu E, Thijs D, Ganame J, Claus P, et al. Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. Eur Heart J. 2009;30:640–641
  31. de Silva R, Raval AN, Hadi M, Gildea KM, Bonifacino AC, Yu ZF, et al. Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulation factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J. 2008;29:1772–1782
  32. Hashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J. 2008;29:251–259
  33. Barbash IM, Chouraqui P, Baron J, Feinbert MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infracted myocardium: feasibility, cell migration, and body distribution. Circ. 2003;108:863–868
  34. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circ. 2005;111:2198–2202

 Supported by grants from Fondo de Investigación Sanitaria [PI060110]; Sociedad Española de Cardiología [2006]; Societat Catalana de Cardiologia [2006]; Hipertensión Esencial: Red de Análisis de Canales iónicos de la musculatura Lisa arterial y su Explotación terapéutica Sistemática [HERACLES, RD06/0009/0008]; Ciber de Enfermedades Respiratorias [06/06/0028], Red temática de investigación cooperativa de la salud [RD06/0003/0008], Fundació Marató TV3 (2007, Malaltires Cardiovascular) and SAF2008-05114-C02-01

PII: S1071-9164(09)01217-2

doi: 10.1016/j.cardfail.2009.12.006

Journal of Cardiac Failure
Volume 16, Issue 4 , Pages 357-366 , April 2010

Article Tools

* Image Usage & Resolution